Search results
Aptose Biosciences Inc. (NASDAQ:APTO) Receives Consensus Rating of “Buy” from Brokerages
ETF DAILY NEWS· 7 hours agoAptose Biosciences Inc. (NASDAQ:APTO – Get Free Report) (TSE:APS) has received a consensus recommendation of “Buy” from the six ratings firms that are presently covering the ...
Tractor Supply Stock Still Looks Like a Buy, Even After Jumping 15% Already This Year
Motley Fool via Yahoo Finance· 1 hour agoAnd the retailer isn't sitting on its laurels. It plans to open 80 new stores in 2024 and then 90...
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
InvestorPlace· 3 hours agoThe ARK Innovation ETF (NYSEARCA:ARKK) has come under the spotlight recently, and there are three...
Goldman Sachs cuts Take-Two stock target, maintains buy rating By Investing.com
Investing.com· 3 hours agoThe firm's analyst cited Take-Two's recent fourth fiscal quarter 2024 earnings report, which...
2 Energy Stocks That Wall Street Fell in Love With This Week
Motley Fool via Yahoo Finance· 30 minutes agoAnd it's not as if the company believes that it has to achieve some extraordinary expansion in...
Coupang (NYSE:CPNG) Rating Increased to Buy at UBS Group
ETF DAILY NEWS· 1 day agoCoupang (NYSE:CPNG – Get Free Report) was upgraded by investment analysts at UBS Group from a “neutral” rating to a “buy” rating in a note issued to investors on Thursday, ...
KNOT Offshore Partners (NYSE:KNOP) Rating Lowered to Buy at StockNews.com
ETF DAILY NEWS· 10 hours agoKNOT Offshore Partners (NYSE:KNOP – Get Free Report) was downgraded by equities research analysts at...
PDS Biotechnology (NASDAQ:PDSB) Rating Reiterated by HC Wainwright
ETF DAILY NEWS· 7 hours agoPDS Biotechnology (NASDAQ:PDSB – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a report issued on Wednesday, Benzinga ...
Mizuho raises Sarepta Therapeutics stock target on FDA hopes By Investing.com
Investing.com· 1 hour agoOn Friday, Mizuho Securities maintained a Buy rating on shares of Sarepta Therapeutics...
Tech, Media & Telecom Roundup: Market Talk
The Wall Street Journal· 2 hours agoHowever, they also highlight management’s comments about online market revenue being soft over the next few quarters, citing reasons such as the lag in...